The pharmaceutical industry is currently experiencing a transformative period marked by evolving clinical trial dynamics, increased R&D investment, and significant post-pandemic adjustments. This transformation is primarily driven by the complexities of modern trials, the demands for
Respiratory Syncytial Virus (RSV) is a common virus that infects nearly all children by the age of two, but while most cases are mild, some children experience severe respiratory illness that requires hospitalization. The mechanisms behind this severity, especially the role and dysfunction of
Mayo Clinic clinicians are leveraging healthcare-specific large language models (LLMs) and generative artificial intelligence (AI) to enhance patient care and improve clinical decisions. This initiative focuses on the implementation and impact of AI-powered tools within medical research and
In a groundbreaking study conducted by researchers at UF Health Cancer Center and their international partners, scientists have found compelling evidence that a toxin produced by a common foodborne bacterium, Campylobacter jejuni (C. jejuni), significantly accelerates the spread of colorectal
Recent research from the University of Alabama at Birmingham (UAB) has unveiled groundbreaking insights into the replication mechanism of the BK polyomavirus (BKPyV), a major cause of kidney transplant failure. This discovery could pave the way for new treatments to protect transplanted kidneys
Prostate cancer has become an alarming health issue, particularly among African men, who are increasingly found to be at higher risk compared to men of other ethnicities. Various studies point towards genetic factors playing a significant role in this elevated risk, coupled with inadequate